Studied by 0 PeopleTags & Description
Powder fineness/Micromeritics
Control tests
→ To check if powder blend can be compacted/compressed
Storage condition and stability test
Control tests
→ To make sure it will reach expiry date/long shelf life
Tablet thickness
→ Important in reproducing tablets identical in appearance, but also to ensure that every production lot will be usable with selected packaging components
→ Also used as counting mechanism using filling equipment
→ Determined with a caliper or thickness gauge
5
Requirement: ⩽ _% of standard thickness (tablet)
Diameter
Factors affecting tablet thickness
_____ of the die
Fill
Factors affecting tablet thickness
Amount of _____ permitted to enter the die
Compaction
The _____ characteristics of the fill material
Stokes Hardness Tester
compressible spring between 2 plungers
Strong-cobb apparatus
pressure operated air pump
Pfizer hardness tester
ordinary pliers
Schleuniger apparatus
most widely used instrument for tablet hardness test
Chewable tablet
Acceptable Hardness:
<2 kg
Buccal tablet
Acceptable Hardness:
10 kg
Acceptable choice
Acceptable Hardness:
3.5 - 7 kg
Application of Content Uniformity (CU) and Weight Variation (WV) Tests for Dosage Forms
Content Uniformity
→ Developed to ensure the content consistency of active pharmaceutical ingredients (API) within a narrow range around the label claim
→ Tablets of 30 are selected from the batch, 10 are assayed
→ Met if the content of each of the 10 tablets is within the limits of 85 and 115% of the average of the limits specified in the potency definition in the individual monograph
10
[Compendial Requirement for Weight Variation Tolerances for Uncoated Tablets]
What’s the % Difference?
<30
7.5
[Compendial Requirement for Weight Variation Tolerances for Uncoated Tablets]
What’s the % Difference?
130-324
5
[Compendial Requirement for Weight Variation Tolerances for Uncoated Tablets]
What’s the % Difference?
324
Disintegration testing
→ Temperature required: 37±2°C
→ Equipment: Basket rack assembly composed of 6 cylindrical tubes w/ 10-mesh wire cloth at bottom portion & disks
Dissolution testing
a physical test to predict drug delivery to a target area in the proper amount at the right time
Dissolution Rate
amount of active ingredient in a solid dosage form dissolved in a unit time under standardized condition of liquid or solid interface temperature and media composition
Rotating Basket
USP apparatus 1 - _____
Standard:
40 mesh
900 mL water
Rotating Paddle
USP apparatus 2 - _____
Standard:
Teflon or stainless
900 mL water
Wire sinker for floaters
Tablets
USP Apparatus 1
_____ (immediate release)
Useful at higher rotation frequencies fort modified-release oral dosage forms (50 rpm)
Capsule
USP Apparatus 2
_____ (immediate release)
More useful at higher rotation frequencies for modified-release oral dosage forms (100 rpm)
Immediate release dosage forms that tend to flat or disintegrate slowly
Type 1 - Basket apparatus
Rot. speed: 50-120 rpm
Dosage form: Conventional tablets, chewable tablets, CR
Type 2 - Paddle apparatus
Rot. speed: 25-50 rpm
Dosage form: Orally disintegrating tablets, chewable tablets, CR, suspensions
Type 3 - Reciprocating cylinder
Rot. speed: 6-35 rpm
Dosage form: CR, chewable tablets
Type 4 - Flow through cell apparatus
Rot. speed: N/A
Dosage forms: ER, poorly soluble API, powder, granules, microparticles, implants
Type 5 - Paddle over disk
Rot. speed: 25-50 rpm
Dosage form: Transdermal
Type 6 - Cylinder (Rotating cylinder)
Rot. speed: N/A
Dosage form: Transdermal
Type 7 - Reciprocating holder
Rot. speed: 30 rpm
Dosage form: CR (non disintegrating oral and transdermal)
Media selection
→ Distilled water is the preferred medium
→ No enzymes should be incorporated
Control test
1.Organoleptic evaluation
2.Assay for the active ingredient(s)
3.Thickness
4.Hardness/Tensile Strength
5.Friability
6.Uniformity of Dosage Units (Weight Variation or Content Uniformity)
7.Disintegration test
8.Dissolution test
Organoleptic
color, odor, texture, taste, shape (surfaces,scoring)
Color (no mottling=irregular color)
Odor (film coated tablets)
Taste (chewable tablets)
Controlling variables
→ Common Operating Speeds: 100 rpm for basket type / 50 rpm for paddle type
→ Temperature: 37+/-0.5°C
→ Usual volume of medium: 500 to 1000 mL, greater volumes (up to 200 mL allowed for drugs with limited solubility)
Control Tests - Capsules
Organoleptic evaluation
Stability tests
Uniformity of Dose
Disintegration test
Dissolution test
Moisture permeation test
Stability tests
[Control test - Capsule]
For capsules are performed to know the integrity of gelatin capsule shell and for determining the shelf-life of capsules. The test helps in improving the quality of contents of capsule shell and for choosing the appropriate retail package.
Shelf-life Determination
[Control test: Stability test - Capsule]
shelf-life or the expiry date of packed capsules is determined under normal storage conditions
Usually stored until 25C
Shell Integrity Test
Performed to find out the integrity of capsule shell
Once the shell is exposed to moisture, they shrink. Silica gel is put so the shell will stay dry
Conditions: 40°C and 80% RH
Standard capsule shells kept at the room temperature 40°C and 80% RH becomes more soft, sticky and swollen.
Disintegration test
[Control test - Capsule]
Should be less than 30 mins.
Dissolution test
[Control test - Capsule]
0.1N HCl resembles the stomach; UV spectrophotometer
Moisture Permeation Test
Assure the suitability of containers for packaging of capsules
Foil/Blister packs: Laminated and air is vacuumed
This test is carried out to assure the suitability of containers for packaging of capsules. The moisture permeating feature of capsules packaged in
Single unit containers-blister pack or strip pack.
Unit dose containers glass or plastic bottle is to be determined
Control Tests - Granules and Powders
▹Particle size analysis
▹Angle of repose
▹Bulk density
▹Tapped density
▹Hausner’s ratio
▹Flowability
▹Stability tests
Stability tests
[Control Tests - Granules and Powders]
spray water/ethanol
Control Tests - Ointments and Creams
Organoleptic evaluation
Assay for active ingredients *to know assay: USP
Test of rate of absorption
Test for non-irritancy *rabbit (skin of rabbit is more sensitive than rats)
Test of rate of penetration
Test of rate of drug release
Test of rheological properties *viscometer
Test of content uniformity
ID test for the active ingredients and possible contaminants
Loss of water/water content *packaging and of drug
pH *pH 4-7
Sterility test
Storage condition *ex: suppositories in the ref
Stability test
Test of rate of absorption
[Control Tests - Ointments and Creams**]**
done in vivo only. The ointment should be applied over a definite area of the skin by rubbing. At regular intervals of time, serum and urine samples should be analyzed for the quantity of drug absorbed.
Test for non-irritancy
[Control Tests - Ointments and Creams**]**
the bases used in the formulation of ointment may cause irritation or allergic reactions.
Non-irritancy is evaluated by patch test. 24 human volunteers are selected. Definite quantity of ointment is applied under occlusion daily on the back or volar fore arm for 21 days. Daily type of pharmacological action observed is noted. No visible reactions or erythema or intense erythema with edema and vesicular erosions should occur.
A good ointment base shows no visible reactions
Test of rate of penetration
[Control Tests - Ointments and Creams**]**
crucial in the onset and duration of action of drug.
Weighed quantity of the preparation should be applied over selected area of the skin for a definite period of time. Then the preparation left over is collected and weighed. (the amount of preparation penetrated divided by the area and period of application gives the rate of penetration of the preparation).
Performed in triplicates
Test of rate of drug release
[Control Tests - Ointments and Creams**]**
ZOI. If bactericidal the agar plate is previously seed with suitable organism such as S. aureus. ZOI is measured and correlated with the rate of release.
Control Tests - Suppositories
Organoleptic evaluation
Physical strength
Melting range *melting point apparatus
Uniformity of drug content
Softening time *the time that the suppository will melt down
Appearance
[Control Tests - Suppositories]
All the suppositories should be uniform size and shape and should have elegant appearance. Suppositories should be examined for cracks and pits on the surface of suppositories.
Physical strength test
[Control Tests - Suppositories]
The strength of the suppositories should be considered to assess their ability during normal handling.
The apparatus used for this is called as breaking test apparatus, which contains a double walled chamber in which water is pumped to maintain 37°C temperature in between the two walls of the chamber.
The inner chamber contains a disc for holding the suppositories. To this disc a rod is attached. The other end of the rod contains a disc for holding the weights.
When the weights are added (upto 200gms) at one minute time interval until the suppositories crumbles.
All the weights used are added which gives the tensile strength.
Tensile strength is the maximum force which the suppository can withstand during production packing and handling. Higher the tensile strength indicates less will be tendency to fracture.
Melting Range Test
Macro melting range
Micro melting range
Macro melting range
[Melting Range Test]
Conducted using the tablet disintegration test apparatus
It gives the measure of thermal stability of the suppository. It is the time taken by the entire suppository to melt in a constant temperature water bath.
The test is conducted using the tablet disintegration test apparatus. The suppository is immersed in a constant water bath, finally the melting range is recorded.
Micro melting range
[Melting Range Test]
Measured using capillary tubes.
▸Measured using capillary tubes.
Test for Softening Time
This test measures the softening or liquefaction time of suppository which indicates the hardness of the base.
The apparatus consists of cellophane tube tied at the two ends of condenser.
The two ends of the cellophane tube are opened. Water is circulated through the condenser at a definite rate.
As a result after sometime the upper half of the tube opens wide and lower half collapses. The time period in which the suppository melts completely is considered as softening time10.
Control Tests - Liquid Dosage Form
Organoleptic evaluation
Assay of active ingredients and degradation products
Pourability
Viscosity
Isotonicity *RBC
Particle size agglomeration and particle size distribution *Coulter counter
Clarity
Physical stability
Relative density
pH
Surface tension
Microbial limit tests
Stability of the active ingredients and identification tests
Light stability *stability cabinet
Container and closure compatibility
Redispersibility
Suspendibility
Storage conditions
Visual
[Control Tests - Liquid Dosage Form]
physical appearance of products for patient adherence and compliance is critical so it should be good looking and elegant in appearance.
Viscosity
[Control Tests - Liquid Dosage Form]
property of liquids that is directly related to the resistance to flow;
viscosity and consistency directly relates with stability of solutions; if viscosity increases; then there is a chance of increase in stability.
Controlled in order to ensure accurate measurement of the volume to be dispensed.
Increasing viscosity of some formulations may increase palatability.
There is a viscosity range that the formulations should exhibit
Isotonicity
[Control Tests - Liquid Dosage Form]
parenterals
Crystallization and precipitation
[Control Tests - Liquid Dosage Form]
concentration of sucrose is determined. Very high – crystallize the syrup; less sucrose conc.- favors microbial growth.
Particle size agglomeration and particle size distribution
[Control Tests - Liquid Dosage Form]
for suspensions and emulsions; shows stability of a disperse system.
Measured using coulter counter and microscopy, Sedimentation by Andreason apparatus.
Clarity
[Control Tests - Liquid Dosage Form]
visual examination of the formulations under light alternatively against white and black backgrounds.
Container and closure compatibility
[Control Tests - Liquid Dosage Form]
torque test
Light-resistant container
[Control Tests - Liquid Dosage Form]
a container intended to provide protection from light.
meets the requirements for Light Transmission
pH control is performed to:
Maintain solubility of therapeutic agent in the formulated product.
Enhance the stability of products in which the chemical stability of the active agent is pH dependent.
The solubility of a vast number of currently available drugs is pH-dependent and therefore, the solubility of the therapeutic agent in the formulation may be compromised by small changes in pH. Unless there are issues re: solubility or stability of the therapeutic agent, the usual pH of oral solutions is 7.0 (5.0 – 8.0).
Container and Closure control
Torque test - is a measure of circular force required to loosen the cap; and application torque is the amount of force used to tighten the cap.
Sample size = 10
The integrity of the seal between closure and container depends on the geometry of the 2, materials used in construction, the composition of cap liner, and tightness applied to the cap.
Geometry-controlled by the mold. Mold number is assigned which is used as its identification number.
Closures should fit the tread of the container. It should sit on a container without tilting, produce no leaks, should not rotate continuously, be reasonably tight.
Minimum titghtness is essential to avoid evap or leakage of product
Excessive torque may break the moulded closures
Caps applied too tightly may be difficult to remove.
Type: I
Type of test: Powdered Glass
[Liquid Dosage Form - Glass Types]
Highly resistant borosilicate glass
Type: II
Type of test: Water attack
[Liquid Dosage Form - Glass Types]
Treated soda-lime glass
Type: III
Type of test: Powdered Glass
[Liquid Dosage Form - Glass Types]
Soda-lime glass
Type: NP
Type of test: Powdered Glass
[Liquid Dosage Form - Glass Types]
General purpose soda-lime glass
Additional Control Tests - Parenteral/Sterile Liquid Dosage Forms
Leaker Test *if may leak; bottle is submerged sa blue dye
Pyrogen Test
Sterility Test
Particulate Matter Evaluation
Uniformity of Content
Ocular Toxicity and Eye Irritation (for eye drops)
Test for preservative efficacy
Container and closure compatibility
[Additional Control Tests - Parenteral/Sterile Liquid Dosage Forms]
torque test
Leaker Test
intended to detect incompletely sealed ampoules or vials so that they can be discarded in order to maintain the sterile conditions of the medicines.
Uses 0.5 – 1.0% methylene blue
Leakage occur when a discontinuity exists in the wall of a package that can allow the passage of gas under the action of a pressure or concentration differential
existing across the wall. Presence of capillary pores or tiny cracks can cause microbes or other dangerous contaminants to enter the ampoules or may lead to the leakage of contents to outside. This may lead to contamination of the sterile contents and also spoilage of appearance of the package.
Changes in temperature during storage can cause expansion and contraction of the ampoule and its contents, there by accentuating interchange if an opening exists. Leaker test for ampoules is intended to detect incompletely sealed ampoules so that they can e discarded in order to maintain the sterile conditions of the medicines.
Tip seal are more likely to be incompletely closed than pull seals.
Open capillaries or cracks at the point of seal result in leakers.
Leakers are detected by this process in a visible manner. Ampoules are placed in a vacuum chamber. Completely submerged in a deeply colored dye solution of about 0.5-1% methylene blue. A negative pressure is applied within the ampoule. Subsequent atmospheric pressure causes the dye to penetrate on opening thus making it visible after the ampoule has been washed. The vacuum, about 27 inches Hg, should be sharply released after 30 minutes. Detection of leakers is prominent when ampoules are immersed in a bath of dye during autoclaving cycle as this has the advantage of accomplishing both leaker detection and sterilization in one operation.
Result: the color from the dye will be visible within a leaker.
Pyrogen Test
Pyrogen test is designed to limit to an acceptable level the risks of febrile reaction in the patient to the administration, by injection, of the product concerned.
Test animals: healthy, mature rabbits.
Rabbits – have similar pyrogen tolerance to humans
Detect non-bacterial endotoxin and bacterial endotoxin pyrogens.
Qualitative only
3 rabbits
Should be acclimatized first (7 days)
Procedure: NMT 30 mins prior to injection of test dose, determine “control temp” of each rabbit. Use only rabbits that do not vary by more than 1 deg.C from each other. Do not use any rabbit having temp exceeding 39.8 deg.C. Record tenoerature at 30 minutes interval between 1 and 3 hours subsequent to the injection.
Requirement: NMT 0.5 deg. Individual rise. If did not meet, add 5 more. NMT 3 of 8 rabbits shows individual rise of 0.5 deg and total temp rise NMT 3.3 deg.
Disadvantages of Pyrogen Test
Biological variation
expensive
Laborious
Dose dependent
Not for antipyretic drug
LAL (Limulus Amebocyte Lysate) Assay
In vitro assay used to detect the presence and concentration of bacterial endotoxins in drugs and biological products.
LAL tube: 1
Result: Negative
[Pyrogen Test - LAL]
Negative Control (Pyrogen free saline)
LAL tube: 2
Result: Positive
[Pyrogen Test - LAL]
Positive Control (Pyrogen)
LAL tube: 3
Result: Positive
[Pyrogen Test - LAL]
Positive internal control (test sample containing exotoxins)
LAL tube: 4
Result: Negative
[Pyrogen Test - LAL]
Test samples
Sterility Test
Reveal the presence or absence of viable microorganisms in a product.
Methods:
Membrane Filtration Method
Direct Inoculation Method
